Tech Company Financing Transactions
Alcyone Lifesciences Funding Round
Alcyone Lifesciences closed a $2.2 million funding round on 7/3/2019. Investors included private investors.
Transaction Overview
Company Name
Announced On
7/3/2019
Transaction Type
Debt
Amount
$2,208,330
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 17 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
116 John St. 300
Lowell, MA 01852
USA
Lowell, MA 01852
USA
Phone
Website
Email Address
Overview
Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
PJ Anand
Chief Financial Officer
Ravi Mehrotra
Chief Marketing Officer
Ottavio Vitolo
Executive Vice President
Susan D'Costa
Vice President
Chris Coletta
VP - Bus. Development
Deep Singh
VP - Product Management
Andrew East
VP - R & D
Bryn Martin
VP - R & D
Gregory Stewart
Browse more venture capital transactions:
Prev: 7/3/2019: AlayaCare venture capital transaction
Next: 7/3/2019: TrapX Security venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs